Aerie Pharmaceuticals
AERI
#6669
Rank
โ‚น69.83 B
Marketcap
โ‚น1,413
Share price
0.00%
Change (1 day)
92.42%
Change (1 year)

Earnings for Aerie Pharmaceuticals (AERI)

Earnings in 2022 (TTM): -โ‚น2.04 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2021 the company made an earning of -โ‚น4.2 Billion, an increase over its 2020 earnings that were of -โ‚น14.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aerie Pharmaceuticals from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น2.04 Billion-51.51%
2021 -โ‚น4.2 Billion-70.07%
2020 -โ‚น14.03 Billion-17.91%
2019 -โ‚น17.09 Billion-19.83%
2018 -โ‚น21.32 Billion59.2%
2017 -โ‚น13.4 Billion50%
2016 -โ‚น8.93 Billion34.29%
2015 -โ‚น6.65 Billion51%
2014 -โ‚น4.41 Billion73.67%
2013 -โ‚น2.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
โ‚น623.02 B-29,027.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น5.67 Billion 162.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น48.41 Billion 2,147.58%๐Ÿ‡บ๐Ÿ‡ธ USA